2022
DOI: 10.1039/d1lc01116b
|View full text |Cite
|
Sign up to set email alerts
|

An immunosensor based on a high performance dual-gate oxide semiconductor thin-film transistor for rapid detection of SARS-CoV-2

Abstract: We present an immunosensor based on a dual-gate oxide semiconductor thin-film transistor as a platform for detecting SARS-CoV-2.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
6
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 11 publications
(6 citation statements)
references
References 29 publications
(33 reference statements)
0
6
0
Order By: Relevance
“…To our best knowledge, the LOD of 0.14 fg ml −1 is the record sensitive EGFET based S1 protein sensors among literatures. [ 40 ] Moreover, the time‐dependent responses of the 4% device to the increasing concentrations of SARS CoV‐2 spike S1 proteins are shown in Figure S7 (Supporting Information), which indicate that devices have good detection stability, and can be applied to dynamically detect protein concentrations. [ 40 ] However, the devices should be placed in a low‐temperature or nitrogen environment during long‐term storage to avoid oxidation and proteolytic degradation of antibodies (Figure S8, Supporting Information).…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…To our best knowledge, the LOD of 0.14 fg ml −1 is the record sensitive EGFET based S1 protein sensors among literatures. [ 40 ] Moreover, the time‐dependent responses of the 4% device to the increasing concentrations of SARS CoV‐2 spike S1 proteins are shown in Figure S7 (Supporting Information), which indicate that devices have good detection stability, and can be applied to dynamically detect protein concentrations. [ 40 ] However, the devices should be placed in a low‐temperature or nitrogen environment during long‐term storage to avoid oxidation and proteolytic degradation of antibodies (Figure S8, Supporting Information).…”
Section: Resultsmentioning
confidence: 99%
“…[40] Moreover, the time-dependent responses of the 4% device to the increasing concentrations of SARS CoV-2 spike S1 proteins are shown in Figure S7 (Supporting Information), which indicate that devices have good detection stability, and can be applied to dynamically detect protein concentrations. [40] However, the devices should be placed in a low-temperature or nitrogen environment during long-term storage to avoid oxidation and proteolytic degradation of antibodies (Figure S8, Supporting Information). [41] The specificity of the IZO:PEI based biosensors was evaluated by comparing their response of SARS-CoV-2, SARS-CoV-1, and MERS-CoV spike protein in PBS due to their genome similarities.…”
Section: Detection Of Sars-cov-2 Spike S1 Proteinmentioning
confidence: 98%
“…1 While a great deal of effort has gone into developing new ways to treat and prevent the onset of COVID-19, 2−5 it is still affecting many people around the world, and it appears that it will continue to be present for the foreseeable future. 6 At the molecular level, the infection of SARS-CoV-2 is directed via critical interactions between the viral spike protein and human ACE2 protein, 7 catalyzing hydrolysis of the vasoconstrictor peptide angiotensin II. 8,9 To gain a deeper understanding of the interaction observed between SARS-CoV-2 and ACE2, one must first understand the structure of SARS-CoV-2.…”
Section: ■ Introductionmentioning
confidence: 99%
“…1 While a great deal of effort has gone into developing new ways to treat and prevent the onset of COVID-19, 2−5 it is still affecting many people around the world, and it appears that it will continue to be present for the foreseeable future. 6 At the molecular level, the infection of SARS-CoV-2 is directed via critical interactions between the viral spike protein and human ACE2 protein, 7…”
Section: ■ Introductionmentioning
confidence: 99%
See 1 more Smart Citation